Data compiled by Redley Lamar · ChainSifter Intelligence
11Suppliers
11Customers
3Debt Items
1Related Chains
Source-Backed Evidence Depth
Profusa, Inc. (PFSA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
26Total relationships
7Distinct source URLs
16High confidence
0.795Average confidence
2026-07-01Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Profusa, Inc. Suppliers
Ticker
Name
Confidence
Evidence
ASCENT-PARTNERS-FUND-LLC
ASCENT-PARTNERS-FUND-LLC
92%
On April 29, 2026, the Company and Ascent Partners Fund LLC (the “ Holder ”) entered into an amendment (the “ Amendment ”) to that certain Warrant to Purchase Shares of Common Stock of the Company, d…
BIO-INSIGHTS-LLC
BIO-INSIGHTS-LLC
92%
pursuant to the Asset Purchase Agreement, Seller agreed to sell, convey, assign, transfer, and deliver to the Company substantially all of the know-how assets relating to Seller’s PanOmics Assay
BIOTIUM
BIOTIUM
92%
all of our reference dye from Biotium
LAURUS-LABS
LAURUS-LABS
92%
all of our glucose sensing dye from Laurus Labs
MAYO-FOUNDATION-FOR-MEDICAL-EDUCATION-AND-RESEAR
MAYO-FOUNDATION-FOR-MEDICAL-EDUCATION-AND-RESEAR
92%
Under the License Agreement, Mayo granted the Company an exclusive, worldwide license (with the right to sublicense) to certain patent rights and a non-exclusive license to related know-how.
MICROBEADS-AS
MICROBEADS-AS
92%
currently we purchase all of the microbeads used in our Lumee Oxygen hydrogel from Microbeads AS
NORTHVIEW-SPONSOR-I-LLC
NORTHVIEW-SPONSOR-I-LLC
92%
On April 24, 2026, Profusa, Inc. (the “ Company ”) entered into that certain Note Modification and Conversion Agreement (the “ Agreement ”) with NorthView Sponsor I LLC (the “ Holder ”), to amend tha…
ROCHE
ROCHE
92%
all of our bacterial catalase from Roche
ASCENT
ASCENT
90%
On February 11, 2025, Northview executed a Securities Purchase Agreement (the “PIPE Subscription Agreement”) with Ascent Partners Fund LLC (“Ascent” or together with any party who may become party to…
SELLER
SELLER
90%
The Purchased Assets include all proprietary methodologies, data, processes, algorithms, software, databases, laboratory notebooks, goodwill, and other assets relating to the PanOmics Assay, but expr…
BIO-INSIGHTS
BIO-INSIGHTS
85%
During the term of the LOI (the “Exclusivity Period”), Bio Insights and its affiliates and representatives are prohibited from soliciting, initiating or encouraging any inquiry or proposal, engaging …
Profusa, Inc. Customers
Ticker
Name
Confidence
Evidence
ASCENT
ASCENT
85%
On July 28, 2025, the Company entered into the ELOC Purchase Agreement and a related registration rights agreement with Ascent.
ASCENT-PARTNERS-FUND-LLC
ASCENT-PARTNERS-FUND-LLC
62%
ndition or results of operations could be materially adversely affected by instability or changes in a country’s or region’s economic conditions; inflation; changes in laws or regulations or in the i…
BEST-LIFE-TECHNOLOGY-LTD
BEST-LIFE-TECHNOLOGY-LTD
62%
ndition or results of operations could be materially adversely affected by instability or changes in a country’s or region’s economic conditions; inflation; changes in laws or regulations or in the i…
BIO-INSIGHT-LLC
BIO-INSIGHT-LLC
62%
ndition or results of operations could be materially adversely affected by instability or changes in a country’s or region’s economic conditions; inflation; changes in laws or regulations or in the i…
BIO-INSIGHTS-LLC
BIO-INSIGHTS-LLC
62%
ndition or results of operations could be materially adversely affected by instability or changes in a country’s or region’s economic conditions; inflation; changes in laws or regulations or in the i…
NORTHVIEW-ACQUISITION-CORPORATION
NORTHVIEW-ACQUISITION-CORPORATION
62%
ng convertible preferred stock converted into shares of the Company’s common stock. Government Grants The Company receives payments from government entities under non-refundable grants in support of …
NORTHVIEW-SPONSOR-I-LLC
NORTHVIEW-SPONSOR-I-LLC
62%
f accounting, the reverse recapitalization was treated as the equivalent of Legacy Profusa issuing stock for the net assets (liabilities) of Northview, accompanied by a recapitalization. The net asse…
NVAC-SPONSOR-I-LLC
NVAC-SPONSOR-I-LLC
62%
the estimated amount. Under an advisory agreement with The Benchmark Company, LLC, the Company may be required to pay up to an additional $ 0.3 million in advisory fees. As of the balance sheet date,…
NV-PROFUSA-MERGER-SUB-INC
NV-PROFUSA-MERGER-SUB-INC
62%
the Merger Agreement and Plan of Reorganization, dated November 7, 2022 (as amended, the “Merger Agreement”), among Northview, Legacy Profusa, and NV Profusa Merger Sub Inc., a wholly-owned Delaware …
PROFUSA-ASIA-PACIFIC-PTE-LTD
PROFUSA-ASIA-PACIFIC-PTE-LTD
62%
eller’s PanOmics Assay, an integrated NGS multi-omics analysis platform used in drug discovery and precision medicine (the “Purchased Assets”). The Purchased Assets include proprietary methodologies,…
SIEMENS-HEALTHINEERS-PERIMED-AB-SENTEC-AG
SIEMENS-HEALTHINEERS-PERIMED-AB-SENTEC-AG
62%
Medtronic markets and sells a standalone glucose monitoring product called Guardian Connect both internationally and in the United States. Medtronic and other third parties have developed or are deve…
Profusa, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
PFSA-DEBT-11748
Warrants outstanding: 233822
90%
xbrl warrant detail from xbrl 2026-03-31.
PFSA-DEBT-11749
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-09-30.
PFSA-DEBT
Debt stack $14.8M
90%
Market cache reports total debt of $14.8M.
Profusa, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Profusa, Inc..
Profusa, Inc. Ownership
Holder
Name
Confidence
Evidence
PFSA-OWNER-UBS-GROUP-AG
UBS Group AG
90%
13F overlay lists UBS Group AG as top holder; 10 tracked holders.
